Evidence map›Paper›PMID 29121595›Full record

Trial reportJournal of psychiatric research2018

From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.

Ricardo E Carrión, Deborah J Walder, Andrea M Auther, Danielle McLaughlin, Heather O Zyla, Steven Adelsheim, Roderick Calkins, Cameron S Carter, Bentson McFarland, Ryan Melton and 6 more

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of psychiatric research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes.The British journal of psychiatry : the journal of mental science · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ten years ofSchizophrenia research. Cognition · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Ricardo E CarriónDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 11030, USA; Department of Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA. Electronic address: RCarrion@northwell.edu.
Deborah J WalderDepartment of Psychology, Brooklyn College, The Graduate Center of the City University of New York, Brooklyn, NY, USA.
Andrea M AutherDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Department of Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Danielle McLaughlinDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Heather O ZylaDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Steven AdelsheimDepartment of Psychiatry, Stanford University, Palo Alto, CA, USA.
Roderick CalkinsMid-Valley Behavioral Care Network, Marion County Health Department, Salem, OR, USA.
Cameron S CarterImaging Research Center, University of California Davis, Sacramento, CA, USA; Center for Neuroscience, University of California Davis, Sacramento, CA, USA.
Bentson McFarlandDepartment of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
Ryan MeltonRegional Research Institute for Human Services, Portland State University, Portland, OR, USA.
Tara NiendamImaging Research Center, University of California Davis, Sacramento, CA, USA.
J Daniel RaglandImaging Research Center, University of California Davis, Sacramento, CA, USA.
Tamara G SaleRegional Research Institute for Human Services, Portland State University, Portland, OR, USA.
Stephan F TaylorDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
William R McFarlaneMaine Medical Center Research Institute, Portland, ME, USA; Tufts University School of Medicine, Boston, MA, USA.
Barbara A CornblattDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 11030, USA; Department of Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Molecular Medicine, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Northwell Health · USUniversity of California, Davis · USPortland State University · USOregon Health & Science University · USPalo Alto University · USThe Graduate Center, CUNY · USTufts University · USUniversity of Michigan · US

Funding

Trials Operation UnitP30MH074543 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2005 to 2009
$8.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
PATHOPHYSIOLOGY OF COGNITIVE DISABILITY IN SCHIZOPHRENIAR01MH059883 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CARTER, CAMERON S. · 2000 to 2017
$6.1M
CHARACTERIZATION OF PRODROMAL SCHIZOPHRENIAR01MH061523 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI CORNBLATT, BARBARA A. · 2000 to 2009
$3.6M
Neural Mechanisms of Memory Dysfunction in SchizophreniaR01MH105411 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RAGLAND, JOHN D, RANGANATH, CHARAN · 2015 to 2018
$1.9M
Cognitive Neuroscience of the Psychosis ProdromeK23MH087708 · NIMH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NIENDAM, TARA ANN · 2010 to 2014
$784k
Magnetic Resonance Spectroscopy in the Psychosis Risk SyndromeR21MH101676 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TAYLOR, STEPHAN F · 2013 to 2014
$428k
NIMH NIH HHS K23 MH087708NIMH NIH HHS P30 MH074543NIMH NIH HHS R01 MH059883NIMH NIH HHS R01 MH061523NIMH NIH HHS R01 MH105411NIMH NIH HHS R21 MH101676NIMH NIH HHS U01 MH081857
6 · The paper itself

Abstract

Cognitive deficits have an important role in the neurodevelopment of schizophrenia and other psychotic disorders. However, there is a continuing debate as to whether cognitive impairments in the psychosis prodrome are stable predictors of eventual psychosis or undergo a decline due to the onset of psychosis. In the present study, to determine how cognition changes as illness emerges, we examined baseline neurocognitive performance in a large sample of helping-seeking youth ranging in clinical state from low-risk for psychosis through individuals at clinical high-risk (CHR) for illness to early first-episode patients (EFEP). At baseline, the MATRICS Cognitive Consensus battery was administered to 322 individuals (205 CHRs, 28 EFEPs, and 89 help-seeking controls, HSC) that were part of the larger Early Detection, Intervention and Prevention of Psychosis Program study. CHR individuals were further divided into those who did (CHR-T; n = 12, 6.8%) and did not (CHR-NT, n = 163) convert to psychosis over follow-up (Mean = 99.20 weeks, SD = 21.54). ANCOVAs revealed that there were significant overall group differences (CHR, EFEP, HSC) in processing speed, verbal learning, and overall neurocognition, relative to healthy controls (CNTL). In addition, the CHR-NTs performed similarly to the HSC group, with mild to moderate cognitive deficits relative to the CTRL group. The CHR-Ts mirrored the EFEP group, with large deficits in processing speed, working memory, attention/vigilance, and verbal learning (>1 SD below CNTLs). Interestingly, only verbal learning impairments predicted transition to psychosis, when adjusting for age, education, symptoms, antipsychotic medication, and neurocognitive performance in the other domains. Our findings suggest that large neurocognitive deficits are present prior to illness onset and represent vulnerability markers for psychosis. The results of this study further reinforce that verbal learning should be specifically targeted for preventive intervention for psychosis.

Indexed as

CognitionAdolescentAntidepressive AgentsAntipsychotic AgentsCognitive DysfunctionDisease ProgressionFemaleFollow-Up StudiesHumansMaleMultivariate AnalysisNeuropsychological TestsPatient Acceptance of Health CareProdromal SymptomsProportional Hazards ModelsPsychotic DisordersAntidepressive AgentsAntipsychotic AgentsClinical high riskEarly InterventionEarly PsychosisNeurocognitionNeuropsychologyProdromeSchizophrenia

Identifiers

PMID29121595
PMCPMC7663810
OpenAlexW2766918533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.